cell-mediated immunotherapy (SRI International)

N/A

Report date: 2025/01/26 18:02:47

Base Information

Drug Namecell-mediated immunotherapy (SRI International)

Drug Alias NameTargeted Antigen Loaded Liposomes (SRI International)tumor-targeting liposomes with immunogenic HLA class I restricted peptide (SRI International)

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionHistocompatibility antigens class I modulators

TargetsHistocompatibility antigens class I

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSri International

China Registration ClassN/A

Develop Information

Active CompaniesSri International

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A